Shares of Commerzbank AG (ETR:CBK - Get Free Report) passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of €19.10 ($21.46) and traded as high as €26.18 ($29.42). Commerzbank shares last traded at €26.01 ($29.22), with a volume of 3,787,710 shares.
Commerzbank Price Performance
The company has a quick ratio of 0.36, a current ratio of 6.76 and a debt-to-equity ratio of 12.97. The company has a market capitalization of $31.58 billion, a P/E ratio of 13.61, a P/E/G ratio of 4.82 and a beta of 1.08. The company's 50-day simple moving average is €23.05 and its 200 day simple moving average is €19.10.
Commerzbank Company Profile
(
Get Free Report)
Commerzbank AG provides banking and capital market products and services to private and small business customers, corporate, financial service providers, and institutional clients in Germany, rest of Europe, the Americas, Asia, and internationally. It operates through two segments, Private and Small-Business Customers, and Corporate Clients.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Commerzbank, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Commerzbank wasn't on the list.
While Commerzbank currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
